Belt Buckling Vitrectomy with Endolaser — Cost, Top Hospitals & Success Rates | MyMedicPlus

Belt buckling vitrectomy with endolaser is a combined surgical procedure for the repair of complex or recurrent retinal detachments that combines the mechanical support of scleral buckling with the internal approach of pars plana vitrectomy and the precision of endolaser photocoagulation. This combined approach is employed when the detachment is too complex for either procedure alone, typically in cases with proliferative vitreoretinopathy (PVR), large or multiple retinal breaks, vitreous haemorrhage obscuring the view, or previous failed repair.

Scleral buckling involves placing a silicone band or sponge around the circumference (equator) of the sclera, indenting the wall of the eye and creating a physical ridge that closes retinal breaks from the outside by reducing vitreous traction and bringing the retinal pigment epithelium into contact with the detached neuroretina. The buckle is typically placed under the conjunctiva and secured with sutures, then cryotherapy is applied to the sclera overlying the retinal breaks to create chorioretinal adhesion.

Vitrectomy — removal of the vitreous gel through three sclerotomy ports in the pars plana region — is performed concurrently to address internal traction, remove proliferative membranes, drain subretinal fluid internally, and position the retina under direct visualisation. Modern small-gauge vitrectomy (23-gauge, 25-gauge) uses self-sealing sclerotomies, reducing surgical trauma and recovery time. Endolaser photocoagulation, delivered through a laser probe inserted through one of the sclerotomy ports, creates permanent chorioretinal adhesion around the breaks and any areas of thin or degenerated retina under direct intraoperative visualisation.

Following reattachment and laser treatment, a tamponade agent (air, sulphur hexafluoride SF6, perfluoropropane C3F8, or silicone oil) is injected to hold the retina against the RPE while the laser-induced adhesion matures. The choice of tamponade depends on the extent of detachment, need for long-term support, and patient ability to maintain positioning.

This combined procedure is primarily indicated for complex rhegmatogenous retinal detachments (caused by a break in the retina) that are associated with proliferative vitreoretinopathy (PVR) — scar tissue formation on the retinal surface causing multiple tractional forces that cannot be relieved by buckling alone. Grade C or D PVR (Retina Society Classification) with fixed retinal folds is the most challenging indication and typically requires vitrectomy for membrane peeling combined with scleral support.

Other indications include giant retinal tears (tear extending more than 90 degrees of circumference), recurrent retinal detachments after failed primary repair, posterior retinal breaks that are difficult to support with external buckling alone, proliferative diabetic retinopathy with tractional retinal detachment extending to the macula, and retinal detachment in eyes with previously placed silicone oil requiring combination surgical approach.

Patients with complex rhegmatogenous retinal detachments involving PVR, large breaks, multiple breaks distributed around the circumference, or previous failed scleral buckle or vitrectomy are the primary candidates for combined belt buckle vitrectomy with endolaser. The decision to combine approaches rather than use either alone is made based on preoperative fundus examination, B-scan ultrasonography (when media opacity prevents direct view), and the surgeon's assessment of tractional forces.

Contraindications include patients medically unfit for the 2-4 hour surgical procedure, those with end-stage glaucoma or severe optic nerve damage where visual recovery is not expected, uncontrolled diabetes with very active proliferative retinopathy, and patients unable to maintain required post-operative positioning (typically face-down for 5-7 days when gas tamponade is used). Relative contraindications include single-eyed patients (greater caution required) and those with severe contralateral eye disease.

The surgical approach begins with placing the scleral buckle (360-degree silicone band or segmental sponge element over the break site) before performing vitrectomy, as this prevents post-vitrectomy hypotony and aids retinal localisation. Alternatively, some surgeons perform vitrectomy first and place the buckle after. Modern 23-gauge or 25-gauge vitrectomy systems allow self-sealing sclerotomies and high-speed cutting (5,000-10,000 cuts/minute) that minimise retinal traction during vitreous removal.

Following core vitrectomy, membrane peeling (internal limiting membrane and epiretinal membrane removal with end-gripping forceps) addresses PVR. Perfluorocarbon liquid (PFCL) — a heavy liquid — can be injected to flatten the retina and displace subretinal fluid toward the breaks for internal drainage. Endolaser photocoagulation is then applied around all breaks and areas of degeneration under direct visualisation with a wide-angle viewing system. Fluid-air exchange and finally gas or silicone oil tamponade are performed before sclerotomy closure. The treating surgeon individualises the chosen technique based on patient anatomy, the extent and nature of the underlying condition, available equipment, and the balance of procedural benefit against risk — a decision made in consultation with the patient following a thorough informed consent discussion covering all available options. The treatment team works closely with patients and their families throughout the entire care pathway, from initial diagnosis and pre-operative preparation through to post-operative recovery and long-term follow-up.

Combining scleral buckling with vitrectomy and endolaser provides the highest anatomical reattachment rates for complex retinal detachments. Single-surgery anatomical success rates of 75-90% are reported for PVR-associated detachments, compared to 50-70% for vitrectomy alone in the same population. For non-PVR complex detachments, single-surgery success approaches 90-95%. Final anatomical reattachment (after any necessary re-operations) is achieved in 95%+ of cases.

Functional visual recovery depends heavily on the duration and extent of macular involvement. When the macula is on (attached), most patients retain good central vision; when the macula is detached, visual outcome is more guarded but meaningful recovery to reading vision (6/18-6/60) is achieved in 50-70% of patients with prompt repair. The combination procedure also reduces recurrence rates compared to either approach alone, making it the standard of care for high-risk complex detachments.

Common complications include transient elevated intraocular pressure (particularly with gas tamponade), cataract formation (occurs in virtually all phakic eyes within 1-2 years of vitrectomy), persistent epithelial downgrowth from sclerotomy sites, and corneal epithelial defects. Silicone oil emulsification with late elevated IOP occurs in 10-20% of eyes with oil tamponade retained beyond 3-6 months, necessitating oil removal.

Serious complications include persistent or recurrent retinal detachment requiring re-operation (10-20% in PVR cases), endophthalmitis (infection inside the eye, occurring in 0.1-0.5% of vitrectomies, requiring emergency treatment), macular pucker (epiretinal membrane re-formation) causing visual distortion, and hypotony (persistently low IOP) from cyclodialysis or sclerotomy leaks. The risk of PVR re-formation and tractional re-detachment remains the major long-term challenge in complex cases. All risks are discussed in detail during the informed consent process prior to the procedure. Patients are encouraged to ask questions and to disclose all medications, allergies, and relevant medical history to enable the surgical and anaesthetic team to minimise avoidable risks and plan safe perioperative care.

Post-operatively, patients must maintain strict face-down positioning for 5-7 days when gas tamponade is used, to ensure the gas bubble floats against the superior retina and reattachment area. Positioning compliance is critical for success and patients are counselled extensively before surgery. Air travel is prohibited while intraocular gas is present (risk of gas expansion with altitude change causing acute elevated IOP and vascular occlusion).

Ophthalmology review is scheduled at 1 week, 1 month, 3 months, and 6 months. Visual acuity, IOP, and fundus examination assess retinal reattachment and monitor for complications. Silicone oil removal, if used, is planned at 3-6 months once the retina is stable. Scleral buckle explantation is rarely required but may be needed if the buckle erodes or causes late complications. Spectacle correction after retinal surgery commonly addresses induced refractive changes.

Belt buckling vitrectomy with endolaser is a technically demanding procedure performed by vitreoretinal subspecialists. In the United States, surgical costs range from $5,000-$15,000, excluding anaesthesia, operating room, and hospital facility fees, which bring the total to $15,000-$35,000. In the UK, NHS treatment is available with waiting times; private costs range from £6,000-£15,000.

In India, Thailand, and Turkey, combined vitreoretinal surgery at JCI-accredited ophthalmology centres costs $2,000-$6,000 total, representing savings of 70-85%. L V Prasad Eye Institute (India), Aravind Eye Care System (India), Snec (Singapore), and Bumrungrad International (Thailand) are internationally recognised vitreoretinal centres with published outcomes. Given the complexity of retinal surgery, surgeon experience and facility capability should be prioritised over cost savings when choosing international centres. International patients should factor in the cost of pre-operative testing, post-operative accommodation during recovery, translation services where required, and travel insurance including medical evacuation cover when planning overseas medical treatment.

Scleral buckling alone remains appropriate for uncomplicated rhegmatogenous retinal detachments without PVR, achieving success rates of 80-90% without vitrectomy. It preserves the natural lens and vitreous and avoids the cataract acceleration associated with vitrectomy.

Vitrectomy alone (without scleral buckle) is the approach preferred by many modern vitreoretinal surgeons for primary detachments, particularly in pseudophakic (post-cataract surgery) eyes where gas tamponade alone provides adequate support. The choice between buckle alone, vitrectomy alone, or combined depends on the individual anatomy, surgeon experience, patient factors, and break characteristics. Pneumatic retinopexy — office-based injection of gas followed by laser or cryotherapy — is an alternative for selected simple superior detachments with a single break, but has no role in complex PVR-associated detachments.